Peak Concentration (Cmax)
Also known as: Cmax
Peak concentration (Cmax) is the maximum drug concentration reached in the blood following a dose. For most subcutaneously injected peptides, Cmax occurs approximately 1–4 hours after injection.
Overview
Cmax is a key pharmacokinetic parameter that describes the highest systemic exposure achieved after a single dose. For subcutaneous peptide administration, absorption from the subcutaneous tissue into circulation takes time, producing a gradual rise to Cmax followed by a decline governed by the compound's elimination rate. The time to reach Cmax (Tmax) varies by peptide, injection site vascularity, and individual factors. Cmax is relevant to research design because some peptide effects are concentration-dependent: pulsatile GH secretion, for example, is driven by transient peaks above a threshold rather than sustained low-level stimulation. Understanding when Cmax occurs helps researchers time collection of outcome measures (e.g., blood draws for GH or IGF-1 levels) appropriately.
Frequently asked questions
What is Tmax and how does it relate to Cmax?+
Tmax is the time after dosing at which Cmax is reached. For subQ peptide injections, Tmax is typically 1–4 hours. Cmax is the concentration value; Tmax is the time at which it occurs.
Does Cmax increase proportionally with dose?+
For compounds following linear pharmacokinetics, doubling the dose approximately doubles Cmax. Some compounds show non-linear kinetics at higher doses due to saturable absorption or elimination.
Why does Cmax timing matter in research?+
If a study measures GH levels to assess peptide effect, blood draws must be timed near Tmax to capture the peak response. Draws taken too early or too late will underestimate the effect.